IRMD vs GEHC

For growth investors, IRadimed Corporation (IRMD) is the stronger pick with 14.

4% revenue growth year-over-year, versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate IRadimed Corporation (IRMD) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, GE HealthCare Technologies Inc.

(GEHC) is the cheapest at 13. 5x versus IRadimed Corporation at 49. 6x. On forward P/E, GE HealthCare Technologies Inc. is actually cheaper at 12. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: IRadimed Corporation wins at 0. 58x versus GE HealthCare Technologies Inc. 's 19. 78x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, IRadimed Corporation (IRMD) delivered a total return of +214.

1%, compared to +2. 9% for GE HealthCare Technologies Inc. (GEHC). Over 10 years, the gap is even starker: IRMD returned +433. 9% versus GEHC's +2. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), IRadimed Corporation (IRMD) is the lower-risk stock at 0.

85β versus GE HealthCare Technologies Inc. 's 1. 37β — meaning GEHC is approximately 61% more volatile than IRMD relative to the S&P 500.

By revenue growth (latest reported year), IRadimed Corporation (IRMD) is pulling ahead at 14.

4% versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). On earnings-per-share growth, the picture is similar: IRadimed Corporation grew EPS 16. 7% year-over-year, compared to 4. 8% for GE HealthCare Technologies Inc.. Over a 3-year CAGR, IRMD leads at 16. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

IRadimed Corporation (IRMD) is the more profitable company, earning 26.

8% net margin versus 10. 1% for GE HealthCare Technologies Inc. — meaning it keeps 26. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRMD leads at 31. 2% versus 13. 4% for GEHC. At the gross margin level — before operating expenses — IRMD leads at 76. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, IRadimed Corporation (IRMD) is the more undervalued stock at a PEG of 0. 58x versus GE HealthCare Technologies Inc. 's 19. 78x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, GE HealthCare Technologies Inc. (GEHC) trades at 12. 4x forward P/E versus 42. 9x for IRadimed Corporation — 30. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IRMD: 38. 3% to $120. 00.

All stocks in this comparison pay dividends.

IRadimed Corporation (IRMD) offers the highest yield at 1. 3%, versus 0. 2% for GE HealthCare Technologies Inc. (GEHC).

For long-horizon retirement investors, IRadimed Corporation (IRMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

85), 1. 3% yield, +433. 9% 10Y return). Both have compounded well over 10 years (IRMD: +433. 9%, GEHC: +2. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IRMD is a small-cap quality compounder stock; GEHC is a mid-cap deep-value stock. IRMD pays a dividend while GEHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.